Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors
Year: 2010
Type: article
Source: Cancer Cell
Authors: Julian Carretero, Takeshi Shimamura, Klarisa Rikova, Autumn L. Jackson, Matthew D. Wilkerson, Christa L. Borgman, Matthew S. Buttarazzi, Benjamin A. Sanofsky, Kate L. McNamara, Kathleyn A. Brandstetter, Zandra E. Walton, Ting-Lei Gu, Jeffrey C. Silva, Katherine Crosby, Geoffrey I. Shapiro, Sauveur-Michel Maira, Hongbin Ji, Diego H. Castrillon, Carla F. Kim, Carlos García-Echeverría, Nabeel Bardeesy, Norman E. Sharpless, Neil D. Hayes, William Y. Kim, Jeffrey A. Engelman, Kwok-Kin Wong
Institutions: Universitat de València, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Cell Signaling Technology (United States), University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Dana-Farber/Harvard Cancer Center, Novartis (Switzerland), Novartis Institutes for BioMedical Research, Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences, Center for Excellence in Molecular Cell Science, The University of Texas Southwestern Medical Center, Boston Children's Hospital, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2114408324